Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,994 | 120 | 81.8% |
| Consulting Fee | $1,620 | 1 | 16.6% |
| Entertainment | $144.43 | 1 | 1.5% |
| Education | $17.84 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| EyePoint Pharmaceuticals US, Inc. | $1,962 | 7 | $0 (2023) |
| Bausch & Lomb Americas Inc. | $1,744 | 25 | $0 (2024) |
| ABBVIE INC. | $872.02 | 14 | $0 (2024) |
| Alcon Vision LLC | $705.32 | 12 | $0 (2024) |
| RxSight Inc | $693.39 | 8 | $0 (2024) |
| Allergan, Inc. | $630.21 | 9 | $0 (2021) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $373.03 | 5 | $0 (2021) |
| Genentech USA, Inc. | $302.90 | 3 | $0 (2024) |
| Sight Sciences, Inc. | $292.01 | 2 | $0 (2024) |
| Optos, Inc. | $243.09 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,126 | 54 | Bausch & Lomb Americas Inc. ($901.84) |
| 2023 | $2,050 | 26 | Bausch & Lomb Americas Inc. ($686.92) |
| 2022 | $2,566 | 15 | EyePoint Pharmaceuticals US, Inc. ($1,734) |
| 2021 | $507.81 | 7 | Heidelberg Engineering, Inc. ($184.27) |
| 2020 | $513.82 | 6 | Bausch & Lomb, a division of Bausch Health US, LLC ($127.94) |
| 2019 | $501.54 | 7 | Genentech USA, Inc. ($140.00) |
| 2018 | $485.88 | 7 | Allergan Inc. ($374.59) |
| 2017 | $24.83 | 1 | Alcon Laboratories Inc ($24.83) |
All Payment Transactions
123 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $25.82 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $34.86 | General |
| Category: Ophthalmology | ||||||
| 12/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Ophthalmology | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $39.25 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Ophthalmology | ||||||
| 12/06/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Bausch & Lomb Americas Inc. | Stellaris (Device) | Food and Beverage | In-kind items and services | $44.91 | General |
| Category: Ophthalmology | ||||||
| 11/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $16.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/13/2024 | Sight Sciences, Inc. | OMNI SURGICAL SYSTEM (Device) | Food and Beverage | In-kind items and services | $149.94 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Ophthalmology | ||||||
| 11/07/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $2.35 | General |
| Category: Ophthalmology | ||||||
| 11/06/2024 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $48.27 | General |
| Category: Ophthalmology | ||||||
| 10/18/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $147.98 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Bausch & Lomb Americas Inc. | STELLARIS (Device) | Food and Beverage | In-kind items and services | $71.86 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | Bausch & Lomb Americas Inc. | STELLARIS (Device) | Food and Beverage | In-kind items and services | $35.93 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $7.61 | General |
| Category: Ophthalmology | ||||||
| 10/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $3.51 | General |
| Category: Ophthalmology | ||||||
| 10/09/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $107.67 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/03/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $34.84 | General |
| Category: EYE CARE | ||||||
| 10/01/2024 | Bausch & Lomb Americas Inc. | XIPERE (Drug) | Food and Beverage | In-kind items and services | $24.60 | General |
| Category: Ophthalmology | ||||||
| 09/23/2024 | RxSight Inc | RXSIGHT CONTACT LENS (Device), RXSIGHT INJECTOR CARTRIDGE, RXSIGHT INJECTOR HANDPIECE | Food and Beverage | In-kind items and services | $108.66 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/23/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.78 | General |
| Category: Ophthalmology | ||||||
| 09/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $8.71 | General |
| Category: Ophthalmology | ||||||
| 09/20/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $1.28 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 183 | 251 | $44,615 | $18,459 |
| 2022 | 8 | 178 | 256 | $50,058 | $21,320 |
| 2021 | 7 | 140 | 221 | $59,472 | $24,475 |
| 2020 | 1 | 15 | 20 | $3,100 | $2,004 |
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 82 | $18,156 | $7,816 | 43.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $6,330 | $2,593 | 41.0% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 23 | 24 | $5,349 | $1,875 | 35.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 17 | 17 | $4,480 | $1,857 | 41.4% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 23 | 26 | $4,116 | $1,681 | 40.8% |
| 92134 | Imaging of retina | Office | 2023 | 28 | 39 | $2,776 | $1,250 | 45.0% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 14 | 16 | $1,782 | $739.29 | 41.5% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 14 | 25 | $1,626 | $647.26 | 39.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 42 | 105 | $23,508 | $10,347 | 44.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $8,969 | $3,785 | 42.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 19 | 22 | $4,950 | $2,189 | 44.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 21 | 24 | $3,822 | $1,551 | 40.6% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 14 | 14 | $3,730 | $1,285 | 34.4% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 19 | 19 | $2,142 | $905.79 | 42.3% |
| 92134 | Imaging of retina | Office | 2022 | 21 | 23 | $1,666 | $692.75 | 41.6% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2022 | 11 | 18 | $1,271 | $565.15 | 44.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 82 | $18,384 | $8,416 | 45.8% |
| 66984 | Removal of cataract with insertion of lens, simple | Facility | 2021 | 11 | 17 | $20,895 | $7,397 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 33 | 33 | $9,550 | $3,903 | 40.9% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 17 | 17 | $4,537 | $1,951 | 43.0% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 26 | 38 | $2,772 | $1,267 | 45.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2021 | 15 | 20 | $1,740 | $820.52 | 47.2% |
| 92083 | Measurement of field of vision during daylight conditions, extended examination | Office | 2021 | 12 | 14 | $1,594 | $719.89 | 45.2% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 15 | 20 | $3,100 | $2,004 | 64.6% |
About Dr. Eric Crowell, MD
Dr. Eric Crowell, MD is a Ophthalmology healthcare provider based in Austin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/26/2013. The National Provider Identifier (NPI) number assigned to this provider is 1831431006.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Crowell, MD has received a total of $9,776 in payments from pharmaceutical and medical device companies, with $3,126 received in 2024. These payments were reported across 123 transactions from 26 companies. The most common payment nature is "Food and Beverage" ($7,994).
As a Medicare-enrolled provider, Crowell has provided services to 516 Medicare beneficiaries, totaling 748 services with total Medicare billing of $66,257. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Uveitis and Ocular Inflammatory Disease, Ophthalmology
- Location Austin, TX
- Active Since 03/26/2013
- Last Updated 08/26/2025
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1831431006
Products in Payments
- YUTIQ (Drug) $1,946
- OZURDEX (Drug) $956.56
- XIPERE (Drug) $943.57
- RXSIGHT CONTACT LENS (Device) $693.39
- MIEBO (Drug) $568.11
- Centurion (Device) $299.66
- OMNI SURGICAL SYSTEM (Device) $292.01
- Clareon (Device) $271.94
- TEPEZZA (Drug) $242.41
- Humira (Biological) $221.28
- STELLARIS (Device) $213.85
- Spectralis (Device) $184.27
- TEPEZZA (Biological) $171.29
- XDEMVY (Drug) $168.12
- Cequa (Drug) $165.71
- EYLEA HD (Biological) $149.94
- NFC-700 (Device) $144.43
- VABYSMO (Drug) $141.42
- Actemra (Biological) $140.00
- Izervay (Drug) $129.69
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Austin
Vikram Durairaj, Md, MD
Ophthalmology — Payments: $516,103
Dr. Sheila Barbarino, M.d, M.D
Ophthalmology — Payments: $236,894
Dr. Thomas Walters, Md, MD
Ophthalmology — Payments: $217,539
Chirag Jhaveri, M.d, M.D
Ophthalmology — Payments: $211,408
Dr. Steven Dell, M.d, M.D
Ophthalmology — Payments: $177,840
Dr. Aaron Roller, M.d, M.D
Ophthalmology — Payments: $154,063